At what enterprise value was DOMIDEP acquired in 2019?

During the acquisition of DOMIDEP by I SQUARED CAPITAL / UI INVESTISSEMENT / BNP PARIBAS DEVELOPPEMENT in 2019, the company was valued at an estimated revenue multiple of below 5x. The transaction's Enterprise Value is estimated to be in the range of 1b - 4b EUR. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Healthcare & Pharma industry currently tracks an average EBITDA multiple of 15.6x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of DOMIDEP when it was acquired by I SQUARED CAPITAL / UI INVESTISSEMENT / BNP PARIBAS DEVELOPPEMENT?

The estimated EV/EBITDA multiple for DOMIDEP is in the range of 10x - 18x. For comparison, the Healthcare & Pharma sector currently shows an average EBITDA multiple of 15.6x. Join our community for free to access full valuation data and industry trends.

What was the revenue of DOMIDEP at the time of the deal?

The revenue of DOMIDEP at the time of the deal is estimated to be in the range of 250M - 500M EUR. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of DOMIDEP during the acquisition?

DOMIDEP's EBITDA is estimated to be in the range of 50M - 100M EUR. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the DOMIDEP acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the DOMIDEP deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.ui-investissement.com/investissement/domidep/

← DATABASE

Home Database Healthcare & PharmaDOMIDEP

07/2019

DOMIDEP acquired by I SQUARED CAPITAL, UI INVESTISSEMENT & BNP PARIBAS DEVELOPPEMENT

FRANCE Health Providers / Healthcare Facilities / Nursing Homes EV 1b - 4b EUR

Context

I-Squared Capital entered into a binding agreement to acquire a majority stake in Domidep from its founder and a consortium of minority financial investors (UI Gestion, BNP Paribas Developpement, Bpifrance, and Carvest). This acquisition serves as a cornerstone for the acquirer's European healthcare strategy, with a focus on institutionalizing the group's operations and funding further international expansion into markets such as Germany and Belgium. The deal was supported by a significant senior secured term loan of over EUR400 million, along with equity injections from the new sponsor.

DOMIDEP, which reported an EBITDA margin of in 2019, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (15.6x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Founded in 1989, Domidep is the fifth-largest private operator of elderly care homes in France. Headquartered in L'Isle-d'Abeau, the group manages a network of approximately 100 specialized facilities, providing residential care, medical assistance, and dependency services to nearly 7,000 residents. The company stands out as a "pure player" in the French long-term care market, emphasizing local culture by allowing each residence to maintain its own unique name rather than a corporate brand.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2019

2018

Similar deals in Health Providers

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
01/2020	ARDIAN	SANTE CIE	FRANCE	Health Providers
12/2019	CIRCLE HEALTH	BMI HEALTHCARE	UNITED KINGDOM	Clinics / Hospitals
07/2019	TRITON PARTNERS	ALERIS	SWEDEN	Clinics / Hospitals
07/2019	NAXICAP PARTNERS / ARDIAN	EMERA	FRANCE	Nursing Homes
04/2019	COLISÉE	ARMONEA	BELGIUM	Nursing Homes
03/2019	DOMUSVI	RESIDALYA	FRANCE	Nursing Homes
01/2019	HUMANA	CORONARIA HOIVA	FINLAND	Nursing Homes
04/2018	INVESTINDUSTRIAL	LIFEBRAIN	ITALY	Labs (Biology)
03/2018	ICV PARTNERS	OUTPATIENT IMAGING AFFILIATES	UNITED STATES	Radiology
03/2018	THE ADOLFSEN GROUP	FRÖSUNDA	SWEDEN	Healthcare Facilities

REFERENCES

Valuation range: EV 1b - 4b EUR

Revenue range: 250M - 500M EUR

EBITDA range: 50M - 100M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of DOMIDEP by I SQUARED CAPITAL / UI INVESTISSEMENT / BNP PARIBAS DEVELOPPEMENT are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Acquirer: i squared capital / ui investissement / bnp paribas developpement